Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial

NCT02054156 is registered in ClinicalTrials.gov with Bonnie Ramsey as lead sponsor.

NCT NCT02054156
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02054156 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPTIMIZing Treatment for Early Pseudomonas Aeruginosa Infection in Cystic Fibrosis: The OPTIMIZE Multicenter, Placebo-Controlled, Double-Blind, Randomized Trial
Lead sponsor
Bonnie Ramsey
Phase
Phase 3
Overall status
Completed
Start date
June 30, 2014
Completion date
August 23, 2018
Enrollment
221 (actual)
Sites
45

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis